This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2018 Jul;13(7):e122-e123.

doi: 10.1016/j.jtho.2018.03.003.

WAC/RET: A Novel RET Oncogenic Fusion Variant in Non-Small Cell Lung Carcinoma

Vamsidhar Velcheti¹, Russell Madison², Siraj M Ali², Alexa B Schrock³

Affiliations

Affiliations

¹ Cleveland Clinic, Cleveland, Ohio. Electronic address: velchev@ccf.org.
² Foundation Medical, Cambridge, Massashusetts.
³ Foundation Medical, Cambridge, Massachusetts.

PMID: 29935851
DOI: 10.1016/j.jtho.2018.03.003

Free article

Case Reports

WAC/RET: A Novel RET Oncogenic Fusion Variant in Non-Small Cell Lung Carcinoma

Vamsidhar Velcheti et al. J Thorac Oncol. 2018 Jul.

Free article

. 2018 Jul;13(7):e122-e123.

doi: 10.1016/j.jtho.2018.03.003.

Authors

Vamsidhar Velcheti¹, Russell Madison², Siraj M Ali², Alexa B Schrock³

Affiliations

¹ Cleveland Clinic, Cleveland, Ohio. Electronic address: velchev@ccf.org.
² Foundation Medical, Cambridge, Massashusetts.
³ Foundation Medical, Cambridge, Massachusetts.

PMID: 29935851
DOI: 10.1016/j.jtho.2018.03.003

No abstract available

PubMed Disclaimer

Similar articles

[The progress of KIF5B-RET fusion gene in non-small cell lung cancer].
Jin LL, Kong H, Xie WP. Jin LL, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2013 Jul;36(7):524-6. Zhonghua Jie He He Hu Xi Za Zhi. 2013. PMID: 24262090 Review. Chinese. No abstract available.
FRMD4A/RET: A Novel RET Oncogenic Fusion Variant in Non-Small Cell Lung Carcinoma.
Velcheti V, Thawani R, Khunger M, Mukhopadhyay S, Chute DJ, Schrock AB, Ali SM. Velcheti V, et al. J Thorac Oncol. 2017 Feb;12(2):e15-e16. doi: 10.1016/j.jtho.2016.11.274. J Thorac Oncol. 2017. PMID: 28115111 No abstract available.
A Novel Oncogenic RET Fusion Variant in Non-Small Cell Lung Cancer: RELCH-RET.
Jiang H, Xiao M, Qi C, Cai S, Liu F. Jiang H, et al. J Thorac Oncol. 2020 Feb;15(2):e27-e28. doi: 10.1016/j.jtho.2019.08.2510. J Thorac Oncol. 2020. PMID: 32127187 No abstract available.
Unique Genetic Characteristics and Clinical Prognosis of Female Patients with Lung Cancer Harboring RET Fusion Gene.
Qiu Z, Ye B, Wang K, Zhou P, Zhao S, Li W, Tian P. Qiu Z, et al. Sci Rep. 2020 Jun 25;10(1):10387. doi: 10.1038/s41598-020-66883-0. Sci Rep. 2020. PMID: 32587276 Free PMC article.
FDA Approves Pralsetinib for Treatment of Adults With Metastatic RET Fusion-Positive NSCLC.
Wright KM. Wright KM. Oncology (Williston Park). 2020 Oct 9;34(10):406-406;431. doi: 10.46883/ONC.2020.3410.0406. Oncology (Williston Park). 2020. PMID: 33058106 Review.

See all similar articles

Cited by

Long non‑coding RNA HCG11 suppresses the malignant phenotype of non‑small cell lung cancer cells by targeting a miR‑875/SATB2 axis.
Su Z, Chen M, Ding R, Shui L, Zhao Q, Luo W. Su Z, et al. Mol Med Rep. 2021 Aug;24(2):552. doi: 10.3892/mmr.2021.12191. Epub 2021 Jun 3. Mol Med Rep. 2021. PMID: 34080031 Free PMC article.
Catalog of 5' fusion partners in RET+ NSCLC Circa 2020.
Ou SI, Zhu VW. Ou SI, et al. JTO Clin Res Rep. 2020 Mar 30;1(2):100037. doi: 10.1016/j.jtocrr.2020.100037. eCollection 2020 Jun. JTO Clin Res Rep. 2020. PMID: 34589933 Free PMC article. Review.
Circulating microRNA sequencing revealed miRNome patterns in hematology and oncology patients aiding the prognosis of invasive aspergillosis.
Fidler G, Szilágyi-Rácz AA, Dávid P, Tolnai E, Rejtő L, Szász R, Póliska S, Biró S, Paholcsek M. Fidler G, et al. Sci Rep. 2022 May 3;12(1):7144. doi: 10.1038/s41598-022-11239-z. Sci Rep. 2022. PMID: 35504997 Free PMC article.
Discovery Stories of RET Fusions in Lung Cancer: A Mini-Review.
Takeuchi K. Takeuchi K. Front Physiol. 2019 Mar 19;10:216. doi: 10.3389/fphys.2019.00216. eCollection 2019. Front Physiol. 2019. PMID: 30941048 Free PMC article. Review.
Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives.
Fancelli S, Caliman E, Mazzoni F, Brugia M, Castiglione F, Voltolini L, Pillozzi S, Antonuzzo L. Fancelli S, et al. Cancers (Basel). 2021 Mar 4;13(5):1091. doi: 10.3390/cancers13051091. Cancers (Basel). 2021. PMID: 33806299 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information